Latest 10-K annual reports

Alaunos Therapeutics files an amendment to its 2024 Annual Report on Form 10-K to include information on directors, executive officers, corporate governance, and executive compensation.

T1 Energy Inc. files an amendment to its 2024 annual report on Form 10-K to include previously omitted information regarding directors, executive compensation, security ownership, related party transactions, and principal accountant fees, along with updated executive certifications.

Nxu Inc. files an amendment to its annual report on Form 10-K to include previously omitted information regarding directors, executive compensation, and other corporate governance matters.

Owlet, Inc. filed an amendment to its annual report to include previously omitted information regarding directors, executive compensation, security ownership, related transactions, and principal accountant fees.

NEXT-ChemX Corporation's 2024 annual report reveals ongoing financial challenges and operational delays as it strives to commercialize its innovative iTDE technology.

Super League Enterprise filed an amendment to its 2024 annual report on Form 10-K, updating information regarding directors, executive officers, compensation, security ownership, related transactions, and accounting fees.

LanzaTech Global files an amendment to its 2024 annual report, updating information on directors, executive compensation, and related matters, while also addressing a non-binding take-private proposal from Carbon Direct Capital.

MediaCo Holding Inc. files an amendment to its annual report on Form 10-K to include information previously omitted regarding directors, executive compensation, security ownership, related transactions, accounting fees, and exhibits.

DynaResource, Inc. files an amended 10-K/A report, highlighting a 31% increase in revenue and increased production at its San Jose de Gracia gold mine in Mexico for the year ended December 31, 2024.

Quanterix Corporation files an amendment to its annual report to include information required by Part III of Form 10-K, which was initially omitted.

Vacasa, Inc. files an amendment to its 2024 Annual Report on Form 10-K to include previously omitted information regarding directors, executive officers, compensation, and related items.

Moleculin Biotech files an amendment to its 2024 annual report to include certain interactive data file tagging and restate items 10 through 14.

Optinose files an amendment to its 2024 Annual Report on Form 10-K/A to include Part III information and update certain disclosures, coinciding with a pending merger agreement with Paratek Pharmaceuticals.

Cannae Holdings files an amendment to its 2024 annual report, providing detailed information on executive compensation, director independence, and related party transactions following a shift to internal management.

Strata Skin Sciences files an amendment to its 2024 annual report to include information required by Part III of Form 10-K, covering details about directors, executive compensation, and related matters.

NRx Pharmaceuticals files an amendment to its 2024 annual report on Form 10-K to update information regarding directors, executive compensation, security ownership, related transactions, and accounting fees.

Health Catalyst files an amendment to its 2024 Annual Report on Form 10-K to include previously omitted information regarding directors, executive compensation, security ownership, related transactions, and accountant fees.

Forward Air Corporation files Amendment No. 3 to its 2024 Annual Report on Form 10-K/A to include previously omitted information regarding directors, executive officers, corporate governance, executive compensation, security ownership, related transactions, and accounting fees.

Falcons Beyond Global amends its annual report on Form 10-K to update information regarding directors, executive officers, corporate governance, and executive compensation.

Traws Pharma files an amendment to its 2024 annual report to include information previously omitted regarding directors, executive officers, and corporate governance.

Howard Hughes Holdings Inc. files an amendment to its 2024 Annual Report on Form 10-K/A to include information required by Items 10 through 14 of Part III, covering details on directors, executive compensation, and corporate governance.

Viatris files an amendment to its 2024 annual report to include Part III information on directors, executive officers, and compensation, responding to shareholder concerns and detailing strategic initiatives.

Oportun Financial Corporation files an amendment to its 2024 Annual Report on Form 10-K to include previously omitted information regarding directors, executive compensation, security ownership, related transactions, and principal accountant fees.

Knightscope files an amendment to its 2024 annual report to include information on directors, executive officers, compensation, and related matters.

LM Funding America amends its annual report on Form 10-K to update information regarding directors, executive officers, compensation, and related matters.

CNS Pharmaceuticals files an amendment to its 2024 annual report on Form 10-K to include information required by Items 10 through 14 of Part III, which were initially omitted.

CBAK Energy Technology files an amendment to its annual report on Form 10-K to disclose information regarding directors, executive officers, and corporate governance.

Seer, Inc. files an amendment to its 2024 annual report to include information required in Part III, related to directors, executive officers, and corporate governance.

KORE Group Holdings' 2024 10-K filing highlights revenue growth offset by operating losses and material weaknesses in internal controls.

Grindr Inc. files an amendment to its 2024 Annual Report on Form 10-K to include information previously omitted regarding directors, executive compensation, and corporate governance.